| Year |
Title |
Altmetric |
| 2023
|
Rheumatoid arthritis among hispanics in the United States: New evidence for an "hispanic paradox"?.
American Journal of the Medical Sciences.
2023
|
|
| 2022
|
Mimicking the mimicker: Necrotizing sarcoid granulomatosis.
American Journal of the Medical Sciences.
364:466-471.
2022
|
|
| 2022
|
Folic acid and methotrexate use and their association with COVID-19 diagnosis and mortality: A case-control analysis from the UK Biobank.
BMJ Open.
12.
2022
|
|
| 2022
|
Emerging strategies for treating gout.
Current Opinion in Pharmacology.
65.
2022
|
|
| 2022
|
Racial Differences in XO (Xanthine Oxidase) and Mitochondrial DNA Damage-Associated Molecular Patterns in Resistant Hypertension.
Hypertension.
79:775-784.
2022
|
|
| 2022
|
Gout Flare Severity From the Patient Perspective: A Qualitative Interview Study.
Arthritis Care and Research.
74:317-323.
2022
|
|
| 2022
|
Which Attributes Are Most and Least Important to Patients When Considering Gout Flare Burden Over Time? A Best-worst Scaling Choice Study.
Journal of Rheumatology.
49:213-218.
2022
|
|
| 2022
|
Managing Gout in Women: Current Perspectives.
Journal of Inflammation Research.
15:1591-1598.
2022
|
|
| 2021
|
Denosumab did not improve computerized tomography erosion scores when added to intensive urate-lowering therapy in gout: Results from a pilot randomized controlled trial.
Seminars in Arthritis and Rheumatism.
51:1218-1223.
2021
|
|
| 2021
|
Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature review.
Arthritis Research and Therapy.
23.
2021
|
|
| 2021
|
The challenge of gout flare measurement.
Best Practice and Research: Clinical Rheumatology.
35.
2021
|
|
| 2021
|
Variation in serum urate levels in the absence of gout and urate lowering therapy.
BMC Rheumatology.
5.
2021
|
|
| 2021
|
What Represents Treatment Efficacy in Long-term Studies of Gout Flare Prevention? An Interview Study of People with Gout.
Journal of Rheumatology.
48:1871-1875.
2021
|
|
| 2021
|
Higher Serum Urate Levels Are Associated With an Increased Risk for Sudden Cardiac Death.
Journal of Rheumatology.
48:1745-1753.
2021
|
|
| 2021
|
Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities.
Nature Reviews Rheumatology.
17:633-641.
2021
|
|
| 2021
|
Effect of Serum Urate Lowering With Allopurinol on Blood Pressure in Young Adults: A Randomized, Controlled, Crossover Trial.
Arthritis and Rheumatology.
73:1514-1522.
2021
|
|
| 2021
|
Association of Agricultural, Occupational, and Military Inhalants With Autoantibodies and Disease Features in US Veterans With Rheumatoid Arthritis.
Arthritis and Rheumatology.
73:392-400.
2021
|
|
| 2021
|
Flare rate thresholds for patient assessment of disease activity states in Gout.
Journal of Rheumatology.
48:293-298.
2021
|
|
| 2021
|
Which factors predict discordance between a patient and physician on a gout flare?.
Rheumatology.
60:773-779.
2021
|
|
| 2021
|
Efficacy and safety of urate-lowering therapy in people with kidney impairment: A GCAN-initiated literature review.
Rheumatology Advances in Practice.
5.
2021
|
|
| 2021
|
Serum Urate Trajectory in Young Adulthood and Incident Cardiovascular Disease Events by Middle Age: CARDIA Study.
Hypertension.
1211-1218.
2021
|
|
| 2021
|
Tele-monitoring flares using a smartphone app in patients with gout or suspected gout: a feasibility study.
Rheumatology Advances in Practice.
5.
2021
|
|
| 2021
|
Variability in urate-lowering therapy prescribing: A gout, hyperuricemia and crystal-associated disease network (G-CAN) physician survey.
Journal of Rheumatology.
48:152-153.
2021
|
|
| 2020
|
Depressive Symptoms and the Effectiveness of a Urate-Lowering Therapy in a Clinical Trial.
ACR Open Rheumatology.
2:710-714.
2020
|
|
| 2020
|
Cardiovascular safety risks associated with gout treatments.
Expert Opinion on Drug Safety.
19:1143-1154.
2020
|
|
| 2020
|
The experience of a gout flare: a meta-synthesis of qualitative studies.
Seminars in Arthritis and Rheumatism.
50:805-811.
2020
|
|
| 2020
|
Coexistent Hyperuricemia and Gout in Rheumatoid Arthritis: Associations With Comorbidities, Disease Activity, and Mortality.
Arthritis Care and Research.
72:950-958.
2020
|
|
| 2020
|
Gout epidemiology and comorbidities.
Seminars in Arthritis and Rheumatism.
50:S11-S16.
2020
|
|
| 2020
|
Gout is associated with an increased risk for incident heart failure among older adults: The REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study.
Arthritis Research and Therapy.
22.
2020
|
|
| 2020
|
How flare prevention outcomes are reported in gout studies: A systematic review and content analysis of randomized controlled trials.
Seminars in Arthritis and Rheumatism.
50:303-313.
2020
|
|
| 2020
|
Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study.
Hypertension.
75:246-256.
2020
|
|
| 2019
|
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.
Annals of the Rheumatic Diseases.
78:1592-1600.
2019
|
|
| 2019
|
Web Exclusive. Annals On Call - Understanding Gout Pathophysiology.
ACP journal club.
170:OC1.
2019
|
|
| 2018
|
An Exercise in Clinical Reasoning: Do You Unpack?.
Journal of General Internal Medicine.
33:1196-1200.
2018
|
|
| 2018
|
Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities.
Arthritis Research and Therapy.
20.
2018
|
|
| 2018
|
Brief Report: Validation of a Definition of Flare in Patients With Established Gout.
Arthritis and Rheumatology.
70:462-467.
2018
|
|
| 2017
|
Rituximab in ANCA-Associated Vasculitis.
Current Rheumatology Reports.
19.
2017
|
|
| 2017
|
Renal dosing of allopurinol results in suboptimal gout care.
Annals of the Rheumatic Diseases.
76.
2017
|
|
| 2016
|
The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale.
Contemporary Clinical Trials.
50:238-244.
2016
|
|
| 2016
|
Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications.
Therapeutic Advances in Musculoskeletal Disease.
8:145-159.
2016
|
|
| 2016
|
Allopurinol Dose Reductions Based on Creatinine Alert Redesign System.
American Journal of Medicine.
129:e95.
2016
|
|
| 2015
|
Serum urate and incident cardiovascular disease: The Coronary Artery Risk Development in Young Adults (CARDIA) study.
PLoS One.
10.
2015
|
|
| 2015
|
Vascular calcifications on hand radiographs in rheumatoid arthritis and associations with autoantibodies, cardiovascular risk factors and mortality.
Rheumatology.
54:1587-1595.
2015
|
|
| 2014
|
A qualitative assessment of internal medicine resident perceptions of graduate medical education following implementation of the 2011 ACGME duty hour standards.
BMC Medical Education.
14.
2014
|
|
| 2014
|
Comorbidities in patients with crystal diseases and hyperuricemia.
Rheumatic Disease Clinics of North America.
40:251-278.
2014
|
|
| 2013
|
Longitudinal association between serum urate and subclinical atherosclerosis: The Coronary Artery Risk Development in Young Adults (CARDIA) study.
Journal of Internal Medicine.
274:594-609.
2013
|
|
| 2013
|
A Delphi exercise to identify characteristic features of gout - Opinions from patients and physicians, the first stage in developing new classification criteria (Journal of Rheumatology (2013) 40, (498-505)).
Journal of Rheumatology.
40:1634.
2013
|
|
| 2013
|
Serum urate association with hypertension in young adults: Analysis from the Coronary Artery Risk Development in Young Adults cohort.
Annals of the Rheumatic Diseases.
72:1321-1327.
2013
|
|
| 2013
|
Association of functional polymorphism rs2231142 (Q141K) in the ABCG2 gene with serum uric acid and gout in 4 US populations.
American Journal of Epidemiology.
177:923-932.
2013
|
|
| 2013
|
A Delphi exercise to identify characteristic features of gout - Opinions from patients and physicians, the first stage in developing new classification criteria.
Journal of Rheumatology.
40:498-505.
2013
|
|
| 2013
|
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.
Nature Genetics.
45:145-154.
2013
|
|
| 2013
|
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.
Nature Genetics.
45:145-154.
2013
|
|
| 2013
|
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.
Nature Genetics.
45:145-154.
2013
|
|
| 2013
|
Thrombosis in vasculitis.
Best Practice and Research: Clinical Rheumatology.
27:57-67.
2013
|
|
| 2012
|
Impact of interactions of cigarette smoking with NAT2 polymorphisms on rheumatoid arthritis risk in African Americans.
Arthritis and Rheumatism.
64:655-664.
2012
|
|
| 2012
|
Drug treatment of hyperuricemia to prevent cardiovascular outcomes: Are we there yet?.
American Journal of Cardiovascular Drugs.
12:1-6.
2012
|
|
| 2012
|
Association between being African-American, serum urate levels and the risk of developing hyperuricemia: Findings from the Coronary Artery Risk Development in Young Adults cohort.
Arthritis Research and Therapy.
14.
2012
|
|
| 2012
|
Developing a provisional definition of flare in patients with established gout.
Arthritis and Rheumatism.
64:1508-1517.
2012
|
|
| 2011
|
Bringing it all together: A novel approach to the development of response criteria for chronic gout clinical trials.
Journal of Rheumatology.
38:1467-1470.
2011
|
|
| 2011
|
Patient-reported outcomes in chronic gout: A report from OMERACT 10.
Journal of Rheumatology.
38:1452-1457.
2011
|
|
| 2011
|
Serum urate in chronic gout - Will it be the first validated soluble biomarker in rheumatology?.
Journal of Rheumatology.
38:1462-1466.
2011
|
|
| 2011
|
Tophus measurement as an outcome measure for clinical trials of chronic gout: Progress and research priorities.
Journal of Rheumatology.
38:1458-1461.
2011
|
|
| 2010
|
Serum urate and its relationship with alcoholic beverage intake in men and women: Findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort.
Annals of the Rheumatic Diseases.
69:1965-1970.
2010
|
|
| 2010
|
Diagnostic Approach to ANCA-associated Vasculitides.
Rheumatic Disease Clinics of North America.
36:491-506.
2010
|
|
| 2009
|
Febuxostat: The evidence for its use in the treatment of hyperuricemia and gout.
Core Evidence.
4:25-36.
2009
|
|
| 2009
|
Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?.
Arthritis Research and Therapy.
11.
2009
|
|
| 2009
|
Are glucocorticoids equivalent to NSAIDs for the treatment of gout flares?.
Nature Reviews Rheumatology.
5:12-13.
2009
|
|
| 2008
|
Management of Hyperuricemia and Gout in CKD.
American Journal of Kidney Diseases.
52:994-1009.
2008
|
|
| 2008
|
Methotrexate is not associated with progression of interstitial lung disease in rheumatoid arthritis.
JAMA Internal Medicine.
168:1927-1928.
2008
|
|
| 2008
|
Serum urate, menopause, and postmenopausal hormone use: from eminence to evidence-based medicine..
Arthritis Research and Therapy.
10:120.
2008
|
|
| 2007
|
Treatment of acute gout-like arthritis in an emergency setting: Prednisolone versus indomethacin: Commentary.
Nature Reviews Rheumatology.
3:604-605.
2007
|
|
| 2007
|
Pulmonary manifestations of rheumatoid arthritis
2007
|
|
| 2006
|
Treatment of rheumatoid arthritis.
American Journal of Health-System Pharmacy.
63:2451-2465.
2006
|
|
| 2005
|
A group randomized trial to improve safe use of nonsteroidal anti-inflammatory drugs.
American Journal of Managed Care.
11:537-543.
2005
|
|
| 2004
|
Cysticercosis as the main cause of partial seizures in children in Peru.
Revista de neurologia.
39:924-926.
2004
|
|
| 1997
|
The role of menopause in the development of chronic mountain sickness.
American Journal of Physiology.
272.
1997
|
|
